China Digest: 3D Med Diagnosis raises $40m; eRoad bags over $14m

China Digest: 3D Med Diagnosis raises $40m; eRoad bags over $14m

China’s oncology diagnosis firm 3D Med Diagnosis

Precision cancer diagnosis firm 3D Med Diagnosis has raised 280 million yuan ($40 million) to spruce up its R&D for its growing product pipeline. In a separate development, human resource SaaS provider eRoad Software has secured over $14 million from SIG and Hillhouse Capital, among others.

3D Med Diagnosis raises $40m

3D Medicines Corporation (3D Med), a precision cancer care medicine company, has announced that its affiliate 3D Med Diagnosis has secured 280 million yuan ($40 million) in its debut funding round after spinning off the division in 2018 to accelerate R&D of its product pipeline, per a company statement. 

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter